Neoral (Novartis) en es it fr

Neoral (Novartis) Brand names, Neoral (Novartis) Analogs

Neoral (Novartis) Brand Names Mixture

  • No information avaliable

Neoral (Novartis) Chemical_Formula


Neoral (Novartis) RX_link

Neoral (Novartis) fda sheet

Neoral_(Novartis) FDA

Neoral (Novartis) msds (material safety sheet)

Neoral (Novartis) Synthesis Reference

No information avaliable

Neoral (Novartis) Molecular Weight


Neoral (Novartis) Melting Point

No information avaliable

Neoral (Novartis) H2O Solubility

No information avaliable

Neoral (Novartis) State


Neoral (Novartis) LogP


Neoral (Novartis) Dosage Forms

Capsule (liquid-filled); Capsule (liquid-filled for emulsion); Solution (oral); Solution (IV infusion)

Neoral (Novartis) Indication

For treatment of transplant rejection, rheumatoid arthritis, severe psoriasis

Neoral (Novartis) Pharmacology

Used in immunosuppression for prophylactic treatment of organ transplants, cyclosporine exerts specific and reversible inhibition of immunocompetent lymphocytes in the G0-or G1-phase of the cell cycle. T-lymphocytes are preferentially inhibited. The T1-helper cell is the main target, although the T1-suppressor cell may also be suppressed. Sandimmune (cyclosporine) also inhibits lymphokine production and release including interleukin-2.

Neoral (Novartis) Absorption

No information avaliable

Neoral (Novartis) side effects and Toxicity

No information avaliable

Neoral (Novartis) Patient Information


Neoral (Novartis) Organisms Affected

Humans and other mammals